Stop the Propofol Infusion and Start Midazolam Infusion
You should immediately discontinue the propofol infusion and transition to midazolam for sedation. Green urine in this patient receiving high-dose propofol for 5 days is a benign manifestation of propofol metabolite excretion, but the more critical concern is the risk of propofol infusion syndrome (PRIS) given the prolonged high-dose administration in this critically ill patient.
Why Stop Propofol Now
The green urine discoloration itself is benign and non-nephrotoxic 1, 2, 3. It occurs when propofol clearance exceeds hepatic elimination capacity, leading to extrahepatic metabolism and renal excretion of green-colored phenolic metabolites 1, 2. This typically resolves within 24 hours of stopping propofol and does not indicate kidney injury 1.
However, the green urine serves as a clinical warning sign that propofol metabolism is saturated. Combined with:
- 5 days of continuous high-dose propofol (exceeding typical short-term use)
- High-dose administration (the scenario describes "high dose IV propofol")
- Critical illness context (MRSA pneumonia, mechanical ventilation, COPD)
This patient is at significant risk for propofol infusion syndrome (PRIS), which carries up to 33% mortality even after discontinuation 4.
Understanding PRIS Risk
PRIS typically occurs with:
- Prolonged administration of propofol doses >70 μg/kg/min
- Can occur even with lower doses 4
- Incidence approximately 1% 4
PRIS manifests as:
- Worsening metabolic acidosis
- Hypertriglyceridemia
- Hypotension with increasing vasopressor requirements
- Cardiac arrhythmias
- Acute kidney injury
- Hyperkalemia
- Rhabdomyolysis
- Liver dysfunction 4
Early recognition and discontinuation of propofol are critically important 4. The variable presentation and lack of diagnostic specificity make detection difficult, but the combination of prolonged high-dose use and green urine should prompt immediate action.
Transition to Midazolam
Midazolam is the appropriate alternative sedative in this scenario:
- Starting dose: 2 mg IV bolus followed by 1 mg/hr infusion 5
- Titration: Give bolus doses equal to or double the hourly infusion rate every 5 minutes as needed for agitation or patient-ventilator dyssynchrony
- Dose adjustment: If patient requires two bolus doses in an hour, double the infusion rate 5
- Continue fentanyl for analgesia (propofol has no analgesic properties) 4
Important Caveats About Midazolam
Be aware that midazolam has its own risks:
- Greater variability and longer time to awakening compared to other sedatives 4
- Propylene glycol toxicity can occur with total daily IV doses as low as 1 mg/kg, manifesting as metabolic acidosis and acute kidney injury 4
- Monitor serum osmol gap (>10-12 mOsm/L suggests propylene glycol accumulation) 4
What NOT to Do
Do not continue propofol: The risk of PRIS outweighs any sedation benefits at this point.
Do not consult nephrology for urgent hemodialysis: Green urine from propofol is not associated with worsening kidney function 1. Hemodialysis is not indicated unless PRIS develops with severe metabolic derangements.
Do not consult ECMO team: There is no indication for ECMO based on green urine alone. ECMO would only be considered if the patient develops refractory cardiopulmonary failure from PRIS or other causes.
Monitoring After Transition
After stopping propofol:
- Monitor for signs of PRIS development (can occur even after discontinuation) 4
- Check triglycerides, lactate, creatine kinase, liver function tests
- Monitor for metabolic acidosis
- Assess renal function
- Green urine should resolve within 24 hours 1, 2
- Watch for propylene glycol toxicity with midazolam (osmol gap, metabolic acidosis)
The green urine is a red flag for propofol overload, not a direct toxicity itself, but it signals the need to change sedation strategy immediately to prevent potentially fatal PRIS.